Nuveen Asset Management, LLC Acadia Pharmaceuticals Inc Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,362,985 shares of ACAD stock, worth $23.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,362,985
Previous 441,849
208.47%
Holding current value
$23.1 Million
Previous $7.18 Million
192.14%
% of portfolio
0.01%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$727 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$235 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$232 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$204 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$101 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.74B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...